July 02, 2026 a 01:00 pm
ELV: Analysts Ratings - Elevance Health Inc.
Elevance Health Inc. stands as a significant entity in the health benefits sector, consistently offering comprehensive care solutions. The latest analyst ratings reveal a stable yet slightly cautious sentiment towards the stock. The mixed ratings, with a leaning towards "Buy," suggest confidence in the company's steady performance and growth prospects despite potential market challenges.
Historical Stock Grades
The current analyst ratings for Elevance Health Inc. underscore a strong inclination towards positive sentiment, predominately in the "Buy" category. As of June 2026, analysts have shown no significant downturn in support for the stock.
| Rating Type | Count | Score Bar |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 12 | |
| Hold | 8 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over recent months, analyst sentiment towards Elevance Health Inc. has shown noticeable stability, with a consistent number of "Buy" ratings. The move from "Strong Buy" to "Buy" in some areas reflects a cautious optimism.
- The total number of ratings has remained stable with a slight flux in specific categories.
- There is a persistent shift from "Strong Buy" towards more "Hold" ratings, indicating a prudent market outlook.
- No ratings in the "Sell" categories demonstrate confidence in the company's core stability.
Percentage Trends
Examining the past periods, a subtle shift is observed in the distribution of analyst recommendations. While "Strong Buy" entries have diminished slightly, the "Hold" ratings have demonstrated a gradual increase, indicating market caution yet enduring confidence.
- Strong Buy ratings decreased from 15% in early 2025 to 10% by mid-2026.
- Buy ratings have consistently ranged around 60% of the total, showing unwavering confidence.
- Hold ratings have seen a moderate increase, signaling a move towards a more conservative analysis.
Latest Analyst Recommendations
A survey of recent ratings shows consistency in opinions by major firms, with no significant downgrades or upgrades at this moment.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-06-08 | Overweight | Overweight | JP Morgan |
| 2026-06-08 | Outperform | Outperform | Mizuho |
| 2026-06-04 | Buy | Buy | B of A Securities |
| 2026-06-04 | Equal Weight | Equal Weight | Morgan Stanley |
| 2026-06-01 | Buy | Buy | Truist Securities |
Analyst Recommendations with Change of Opinion
Recent months reflect both upgrades and downgrades, highlighting a discerning approach by analysts in evaluating Elevance Health Inc.'s stock amidst fluctuating market conditions.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-05-20 | Buy | Hold | Deutsche Bank |
| 2026-04-29 | Buy | Neutral | B of A Securities |
| 2026-01-08 | Outperform | Peer Perform | Wolfe Research |
| 2025-12-19 | Hold | Buy | Deutsche Bank |
| 2025-07-21 | Hold | Buy | Argus Research |
Interpretation
Overall, the analyst community shows confidence in Elevance Health Inc. but with a balance of caution. While the prevalence of "Buy" ratings indicates trust in the company's core functions and growth trajectory, the more frequent "Hold" ratings signal a conservative approach due to potential market challenges. The consistency without dramatic shifts suggests a stable, though cautious, confidence in the stock’s market position. Elevance's broad service offering may be a foundation for this stability, despite uncertainties.
Conclusion
Elevance Health Inc. carries a robust standing with consistent analyst ratings favoring "Buy" over "Hold." The transformations seen over recent months suggest a maturing sentiment focusing more on sustainable growth than rapid appreciation. As the market remains vigilant of potential hurdles such as regulatory adjustments and competitive pressures, analyst assessments continue to value cautious optimism. This balance of sentiments symbolizes potential for calculated investment, pointing to resilience amidst fluctuations in health services demand.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years